Single Use Featured Articles

  1. Budgets For Single-Use Systems On The Rise; CMOs The Biggest Spenders 8/27/2012

    Single-use systems are rapidly becoming mainstream in the biopharmaceutical industry, even in commercial manufacturing.  Results from our 9th Annual Report and Survey of Biopharmaceutical Manufacturers indicate that budgets for single-use components are also on the rise, meaning this trend is likely to continue. By Eric Langer, President and Managing Partner, BioPlan Associates, Inc.

  2. Biomanufacturers Looking For Single-Use Innovations 7/9/2012

    Single-use innovation continues to be a hot topic, according to results from our 9th Annual Report and Survey of Biopharmaceutical Manufacturers. In fact, disposable products account for three of the top five new product development areas of interest this year among the 302 biomanufacturers we surveyed (the study evaluated 21 different new product areas).  By Eric Langer, President and Managing Partner, BioPlan Associates, Inc.

  3. Single-Use Technologies Used Less For Downstream Purification Issues: Interest In Specific Technologies Remains Relatively Steady 4/24/2012

    Downstream operations continue to create challenging bottlenecks and capacity problems. To identify what the industry is doing to address these bottlenecks, we asked 302 biopharmaceutical manufacturers in our 9th Annual Report and Survey of Biopharmaceutical Manufacturers about the specific areas their facility has actually implemented to improve their downstream purification (DSP) operations. By Eric Langer, president and managing partner, BioPlan Associates, Inc.

  4. Overview Of Biomanufacturing Activity And Spend Around The World - Infographic 3/6/2012

    Pharma IQ has created an easy-to-digest overview of biomanufacturing activity and spend around the world, whether they are already being implemented or have plans in the near future. You’ll be able to keep it as a handy reference, share it around your colleagues, or even stick it on your wall!

  5. BioPharma Industry Getting Comfortable With Complex Single-Use Devices 2/10/2012

    The rate of usage of disposables in biopharmaceutical manufacturing has increased substantially over the past six years in a variety of areas, but most notably for complex devices, that are also among the most expensive. By Eric Langer

  6. Biopharma Manufacturers Look For Product Innovation 1/27/2012
    Biopharma manufacturers are increasingly vocal about the new product development (NPD) areas they need to increase productivity and improve quality. By Eric Langer, president and managing partner, BioPlan Associates, Inc.
  7. New Single-Use Devices: Trends And Demands
    Single-Use Biomanufacturing Devices In High Demand     1/5/2012

    Single-use devices are in hot demand as the biopharma industry looks for new, more innovative products. In fact, disposables make up the top 3 of 20 areas of new product development interest this year. By Eric Langer, president and managing partner, BioPlan Associates, Inc.

  8. Poster: Multiplexing Cell Based Assays Using Beckman Coulter Biomek FX Liquid Handler 7/11/2011
    The multifunctional DTX 880 Multimode Detector was used to measure luminescent and fluorescent output signals from the same assay plate.
  9. Economic Analysis Of Single-Use Tangential Flow Filtration For Biopharmaceutical Applications 6/10/2011
    Prior to creating an accurate economic model for TFF, a thorough understanding of the process where the TFF is used is needed. A process model is a valuable tool when properly executed and it must accurately include all critical aspects of the purification process. By Michael LaBreck, Mark Perreault, Novasep
  10. White Paper: Economic Analysis Of Single-Use Tangential Flow Filtration For Biopharmaceutical Applications 6/10/2011
    Prior to creating an accurate economic model for TFF, a thorough understanding of the process where the TFF is used is needed. A process model is a valuable tool when properly executed and it must accurately include all critical aspects of the purification process. By Michael LaBreck, Mark Perreault, Novasep